Study on the Application of ¹⁸F-FCOB04, a MAO-B Targeted PET Imaging Agent, in Neurodegenerative Diseases
NCT07470710
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Neurodegenerative Diseases
Interventions
DRUG:
18F-FCOB04
Sponsor
Peking Union Medical College Hospital